MXPA03007535A - Metodo para extraer virus de cultivo celular. - Google Patents

Metodo para extraer virus de cultivo celular.

Info

Publication number
MXPA03007535A
MXPA03007535A MXPA03007535A MXPA03007535A MXPA03007535A MX PA03007535 A MXPA03007535 A MX PA03007535A MX PA03007535 A MXPA03007535 A MX PA03007535A MX PA03007535 A MXPA03007535 A MX PA03007535A MX PA03007535 A MXPA03007535 A MX PA03007535A
Authority
MX
Mexico
Prior art keywords
cell culture
extracting virus
virus
extracting
culture
Prior art date
Application number
MXPA03007535A
Other languages
English (en)
Inventor
Matthew C Coffey
Original Assignee
Oncolytics Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncolytics Biotech Inc filed Critical Oncolytics Biotech Inc
Publication of MXPA03007535A publication Critical patent/MXPA03007535A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A61K35/765—Reovirus; Rotavirus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12211—Orthoreovirus, e.g. mammalian orthoreovirus
    • C12N2720/12232—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12211—Orthoreovirus, e.g. mammalian orthoreovirus
    • C12N2720/12251—Methods of production or purification of viral material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Wood Science & Technology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • General Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
MXPA03007535A 2001-03-16 2002-03-11 Metodo para extraer virus de cultivo celular. MXPA03007535A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27673401P 2001-03-16 2001-03-16
PCT/CA2002/000331 WO2002074940A1 (en) 2001-03-16 2002-03-11 Method of extracting virus from cell culture

Publications (1)

Publication Number Publication Date
MXPA03007535A true MXPA03007535A (es) 2003-12-11

Family

ID=29420186

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03007535A MXPA03007535A (es) 2001-03-16 2002-03-11 Metodo para extraer virus de cultivo celular.

Country Status (14)

Country Link
US (2) US6808916B2 (es)
EP (2) EP2253701B1 (es)
JP (2) JP4087712B2 (es)
AR (1) AR034216A1 (es)
BR (1) BR0207527A (es)
CA (1) CA2437962C (es)
DK (1) DK2253701T3 (es)
ES (1) ES2500645T3 (es)
HK (1) HK1150859A1 (es)
IL (2) IL157304A0 (es)
MX (1) MXPA03007535A (es)
NZ (1) NZ527525A (es)
WO (1) WO2002074940A1 (es)
ZA (1) ZA200306228B (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1501921B2 (en) * 2002-04-30 2012-07-25 Oncolytics Biotech Inc. Improved viral purification methods
EP1634947A4 (en) * 2003-06-10 2007-10-03 Shimadzu Corp EXTRACT FROM A CULTURED MAMMALIAN CELL, PROCESS FOR THEIR PREPARATION AND METHOD FOR CELL-FREE PROTEIN SYNTHESIS USING THE EXTRACT
US7901921B2 (en) * 2004-10-22 2011-03-08 Oncolytics Biotech Inc. Viral purification methods
US10668119B2 (en) 2005-08-01 2020-06-02 Virocure, Inc. Attenuated reovirus
EP1917351A4 (en) 2005-08-01 2009-12-16 Univ Technologies Int ATTENUATED REOVIRUS
JP5577103B2 (ja) 2007-03-12 2014-08-20 オンコリティクス バイオテク，インコーポレーテッド 改変配列を有するレオウイルス
US10369171B2 (en) 2007-03-13 2019-08-06 Virocure, Inc. Attenuated reoviruses for selection of cell populations
TW200909581A (en) * 2007-05-21 2009-03-01 Oncolytics Biotech Inc Mutant reoviruses and methods of making and using
WO2009052617A1 (en) * 2007-10-22 2009-04-30 Oncolytics Biotech Inc. Treatment regime for proliferative disorders
CN201163385Y (zh) * 2008-01-15 2008-12-10 昆山渝榕电子有限公司 笔记本电脑及其脚垫
US8470312B2 (en) * 2008-05-27 2013-06-25 Oncolytics Biotech, Inc. Abrogating proinflammatory cytokine production during oncolytic reovirus therapy
MX339014B (es) * 2008-05-27 2016-05-09 Oncolytics Biotech Inc Modulacion de presion intersticial y suministro y distribucion viral oncolitica.
EA201390810A1 (ru) 2010-12-02 2013-09-30 Онколитикс Байотек Инк. Жидкие вирусные составы
CN103269716B (zh) 2010-12-02 2015-05-27 昂科利蒂克斯生物科技公司 冻干病毒制剂
KR102151890B1 (ko) 2011-04-29 2020-09-03 온콜리틱스 바이오테크 인코포레이티드 겔 침투 크로마토그래피를 이용한 바이러스의 정제방법
EP2970857A4 (en) * 2013-03-15 2016-11-02 Ansun Biopharma Inc NEW PROTEIN PURIFICATION PROCESS
ES2796950T3 (es) 2013-11-15 2020-11-30 Oncolytics Biotech Inc Virus oncolíticos y regímenes reforzados para tratamiento de cáncer
WO2016130569A1 (en) * 2015-02-09 2016-08-18 Mj Biologics, Inc. A composition comprising pedv antigens and methods for making and using the composition
US10280199B2 (en) 2014-02-07 2019-05-07 Phibro Animal Health Corporation Coronavirus proteins and antigens
EP3172317B1 (en) 2014-07-24 2019-05-01 Janssen Vaccines & Prevention B.V. Process for the purification of poliovirus from cell cultures
GB201417042D0 (en) * 2014-09-29 2014-11-12 Fkd Therapies Oy Method
WO2023277173A1 (ja) * 2021-06-30 2023-01-05 旭化成メディカル株式会社 ウイルスの回収方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5023252A (en) 1985-12-04 1991-06-11 Conrex Pharmaceutical Corporation Transdermal and trans-membrane delivery of drugs
JPS6344532A (ja) 1986-08-11 1988-02-25 Biseibutsu Kagaku Kenkyusho:Kk 豚のレオウイルス感染症ワクチン
US5614413A (en) * 1993-07-01 1997-03-25 The Uab Research Foundation Encapsidated recombinant poliovirus nucleic acid and methods of making and using same
HRP950097A2 (en) * 1994-03-08 1997-06-30 Merck & Co Inc Hepatitis a virus culture process
US6146873A (en) * 1994-11-10 2000-11-14 Baxter Aktiengesellschaft Production of orthomyxoviruses in monkey kidney cells using protein-free media
EP0968284B1 (en) * 1996-11-20 2006-12-13 Introgen Therapeutics, Inc. An improved method for the production and purification of adenoviral vectors
US6214333B1 (en) * 1997-07-08 2001-04-10 Texas Heart Institute Vasoprotective recombinant adenovirus vector containing a human TFPI gene
US6110461A (en) 1997-08-13 2000-08-29 Oncolytics Biotech Inc. Reovirus for the treatment of neoplasia
TWI289158B (en) * 2000-08-10 2007-11-01 Oncolytics Biotech Inc Method of producing infectious reovirus

Also Published As

Publication number Publication date
JP4087712B2 (ja) 2008-05-21
JP2007295937A (ja) 2007-11-15
HK1150859A1 (en) 2012-01-13
CA2437962C (en) 2005-11-15
ZA200306228B (en) 2004-08-12
ES2500645T3 (es) 2014-09-30
US6808916B2 (en) 2004-10-26
WO2002074940A1 (en) 2002-09-26
US20020168764A1 (en) 2002-11-14
US20050095692A1 (en) 2005-05-05
JP2004520841A (ja) 2004-07-15
EP2253701B1 (en) 2014-08-13
IL157304A (en) 2010-04-29
DK2253701T3 (da) 2014-10-20
US7186542B2 (en) 2007-03-06
EP2253701A1 (en) 2010-11-24
IL157304A0 (en) 2004-02-19
EP1370643A1 (en) 2003-12-17
NZ527525A (en) 2005-03-24
BR0207527A (pt) 2004-02-25
AR034216A1 (es) 2004-02-04
CA2437962A1 (en) 2002-09-26

Similar Documents

Publication Publication Date Title
MXPA03007535A (es) Metodo para extraer virus de cultivo celular.
IL161858A0 (en) Cell culture process
AU2002353156A1 (en) System and method for extracting energy from agricultural waste
AU2002314693A1 (en) Nucleic acid amplification method
AU2003217552A1 (en) Selective extraction of dna from groups of cells
AU2003232781A1 (en) Method for nucleic acid extraction and nucleic acid purification
HUP0402337A3 (en) Method for the recovery and purification of poxviruses from infected cells
AU2002234243A1 (en) Dotted micro-array data extraction method
AU3377500A (en) Method for extracting dna from dried specimens
IL158927A0 (en) Method for virus propagation
AU2003294652A1 (en) Method and reactor for the amplification of dna
AU2261802A (en) Method of analyzing gene expression
AU2002222618A1 (en) Method of analyzing gene expression
AU2002311780A1 (en) Methods for isolating genes from microorganisms
ZA200402304B (en) Method for preparing heparin from mast cell cultures.
EG25192A (en) Method of extracting iron-oxides.
TWI318643B (en) Method of extracting virus from cell culture
FI20010221A0 (fi) Menetelmä entsyymin uuttamiseksi
AU2003208649A1 (en) Method of extracting, isolating and purifying sesame protein
AU2001266212A1 (en) Method for dna extraction
AU2003280820A1 (en) Dna amplification method
AU2002358532A1 (en) Method for analyzing translation-controlled gene expression
AU2002300221A1 (en) Method for Introducing Gene into Plant Having Improved Transformation Efficiency
AUPR887901A0 (en) Method for improved nucleic acid extraction
EP1182254A4 (en) METHOD FOR SEPARATION, FRACTIONATION AND ANALYSIS OF GENES FROM VIRUSES THAT EXIST IN WATER

Legal Events

Date Code Title Description
FG Grant or registration